Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.

作者: Ingrid K. Ruf , Paul W. Rhyne , Hui Yang , Corina M. Borza , Lindsey M. Hutt-Fletcher

DOI: 10.1128/MCB.19.3.1651

关键词:

摘要: Loss of the Epstein-Barr virus (EBV) genome from Akata Burkitt lymphoma (BL) cells is coincident with a loss malignant phenotype, despite fact that and other EBV-positive BL express restricted set EBV gene products (type I latency) are not known to overtly affect cell growth. Here we demonstrate reestablishment type latency in EBV-negative restores tumorigenicity tumorigenic potential correlates an increased resistance apoptosis under growth-limiting conditions. The antiapoptotic effect was associated higher level Bcl-2 expression EBV-dependent decrease steady-state levels c-MYC protein. Although EBNA-1 protein expressed all EBV-associated tumors reported have oncogenic potential, enforced alone failed restore or down-regulation c-MYC. These data provide direct evidence contributes suggest novel model whereby program promotes B-cell survival, thus persistence within immune host, by selectively targeting

参考文章(62)
D S Askew, J L Cleveland, B C Simmons, R A Ashmun, Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. ,vol. 6, pp. 1915- 1922 ,(1991)
P.J. Farrell, G.J. Allan, F. Shanahan, K.H. Vousden, T. Crook, p53 is frequently mutated in Burkitt's lymphoma cell lines. The EMBO Journal. ,vol. 10, pp. 2879- 2887 ,(1991) , 10.1002/J.1460-2075.1991.TB07837.X
M. E. Williams, S. H. Swerdlow, C. L. Rosenberg, A. Arnold, Centrocytic Lymphoma: a B-Cell Non-Hodgkin’s Lymphoma Characterized by Chromosome 11 BCL-1 and PRAD 1 Rearrangements Current Topics in Microbiology and Immunology. ,vol. 182, pp. 325- 329 ,(1992) , 10.1007/978-3-642-77633-5_41
D.T. Rowe, M. Rowe, G.I. Evan, L.E. Wallace, P.J. Farrell, A.B. Rickinson, Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells. The EMBO Journal. ,vol. 5, pp. 2599- 2607 ,(1986) , 10.1002/J.1460-2075.1986.TB04540.X
J Sample, E B Henson, C Sample, The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. Journal of Virology. ,vol. 66, pp. 4654- 4661 ,(1992) , 10.1128/JVI.66.8.4654-4661.1992
G J Rosman, A D Miller, Improved Retroviral Vectors for Gene Transfer and Expression BioTechniques. ,vol. 7, pp. 980- 990 ,(1989)
C.D. Laherty, H.M. Hu, A.W. Opipari, F Wang, V.M. Dixit, The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. Journal of Biological Chemistry. ,vol. 267, pp. 24157- 24160 ,(1992) , 10.1016/S0021-9258(18)35741-7
L A Brooks, A L Lear, L S Young, A B Rickinson, Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. Journal of Virology. ,vol. 67, pp. 3182- 3190 ,(1993) , 10.1128/JVI.67.6.3182-3190.1993
J. B. Wilson, J. L. Bell, A. J. Levine, Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. The EMBO Journal. ,vol. 15, pp. 3117- 3126 ,(1996) , 10.1002/J.1460-2075.1996.TB00674.X